2nd Quarter - Report

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Firm
Client
Income
—
Expenses
$351,100
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2013, provisions related to funding for the blood cancer education program

LobbyistCovered position, as disclosed
GEORGE DAHLMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3295 (112th)

Medical/Disease Research/Clinical Labs MED

S. 3187, The Food and Drug Administration Safety and Innovation Act, provisions related to drug shortages

LobbyistCovered position, as disclosed
GEORGE DAHLMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.